KR20200141442A - Oral composition and bitter taste improver of α-olefin sulfonate - Google Patents
Oral composition and bitter taste improver of α-olefin sulfonate Download PDFInfo
- Publication number
- KR20200141442A KR20200141442A KR1020207027262A KR20207027262A KR20200141442A KR 20200141442 A KR20200141442 A KR 20200141442A KR 1020207027262 A KR1020207027262 A KR 1020207027262A KR 20207027262 A KR20207027262 A KR 20207027262A KR 20200141442 A KR20200141442 A KR 20200141442A
- Authority
- KR
- South Korea
- Prior art keywords
- component
- oral composition
- olefin sulfonate
- bitter taste
- linalool
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 63
- 235000019658 bitter taste Nutrition 0.000 title claims abstract description 48
- 239000004711 α-olefin Substances 0.000 title claims abstract description 36
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 title claims abstract description 31
- UWKAYLJWKGQEPM-LBPRGKRZSA-N linalyl acetate Chemical compound CC(C)=CCC[C@](C)(C=C)OC(C)=O UWKAYLJWKGQEPM-LBPRGKRZSA-N 0.000 claims abstract description 28
- KVWWIYGFBYDJQC-UHFFFAOYSA-N methyl dihydrojasmonate Chemical compound CCCCCC1C(CC(=O)OC)CCC1=O KVWWIYGFBYDJQC-UHFFFAOYSA-N 0.000 claims abstract description 28
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 claims abstract description 27
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 22
- UFLHIIWVXFIJGU-ARJAWSKDSA-N (Z)-hex-3-en-1-ol Chemical compound CC\C=C/CCO UFLHIIWVXFIJGU-ARJAWSKDSA-N 0.000 claims abstract description 15
- 239000001278 2-(5-ethenyl-5-methyloxolan-2-yl)propan-2-ol Substances 0.000 claims abstract description 15
- BRHDDEIRQPDPMG-UHFFFAOYSA-N Linalyl oxide Chemical compound CC(C)(O)C1CCC(C)(C=C)O1 BRHDDEIRQPDPMG-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229960004949 glycyrrhizic acid Drugs 0.000 claims abstract description 15
- 235000019410 glycyrrhizin Nutrition 0.000 claims abstract description 15
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 15
- UFLHIIWVXFIJGU-UHFFFAOYSA-N hex-3-en-1-ol Natural products CCC=CCCO UFLHIIWVXFIJGU-UHFFFAOYSA-N 0.000 claims abstract description 15
- UWKAYLJWKGQEPM-UHFFFAOYSA-N linalool acetate Natural products CC(C)=CCCC(C)(C=C)OC(C)=O UWKAYLJWKGQEPM-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 claims abstract description 14
- 150000003839 salts Chemical class 0.000 claims abstract description 14
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 claims abstract description 13
- 229930007744 linalool Natural products 0.000 claims abstract description 13
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 claims description 26
- GEWDNTWNSAZUDX-WQMVXFAESA-N (-)-methyl jasmonate Chemical compound CC\C=C/C[C@@H]1[C@@H](CC(=O)OC)CCC1=O GEWDNTWNSAZUDX-WQMVXFAESA-N 0.000 claims description 13
- 239000005792 Geraniol Substances 0.000 claims description 13
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 claims description 13
- 229940113087 geraniol Drugs 0.000 claims description 13
- GEWDNTWNSAZUDX-UHFFFAOYSA-N methyl 7-epi-jasmonate Natural products CCC=CCC1C(CC(=O)OC)CCC1=O GEWDNTWNSAZUDX-UHFFFAOYSA-N 0.000 claims description 13
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 claims description 8
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 8
- 239000001685 glycyrrhizic acid Substances 0.000 claims description 8
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 8
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims description 6
- 239000000551 dentifrice Substances 0.000 claims description 5
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- CCXAYLQLOLXXKE-DWJAGBRCSA-K trisodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4s,5s,6s)-2-[[(3s,4ar,6ar,6bs,8as,11s,12ar,14ar,14bs)-11-carboxylato-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl]oxy]-6-carboxylato-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-t Chemical compound [Na+].[Na+].[Na+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C([O-])=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O CCXAYLQLOLXXKE-DWJAGBRCSA-K 0.000 claims description 3
- 235000010254 Jasminum officinale Nutrition 0.000 abstract 1
- 240000005385 Jasminum sambac Species 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- -1 alkali metal salts Chemical class 0.000 description 20
- 238000002156 mixing Methods 0.000 description 20
- 239000003205 fragrance Substances 0.000 description 17
- 235000019640 taste Nutrition 0.000 description 15
- 230000000694 effects Effects 0.000 description 13
- 235000014113 dietary fatty acids Nutrition 0.000 description 10
- 239000000194 fatty acid Substances 0.000 description 10
- 229930195729 fatty acid Natural products 0.000 description 10
- 239000000463 material Substances 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 239000004094 surface-active agent Substances 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 239000004480 active ingredient Substances 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 235000003599 food sweetener Nutrition 0.000 description 5
- 210000000214 mouth Anatomy 0.000 description 5
- 239000003765 sweetening agent Substances 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000003082 abrasive agent Substances 0.000 description 4
- 239000003945 anionic surfactant Substances 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- RUTSRVMUIGMTHJ-UHFFFAOYSA-M sodium;tetradec-1-ene-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCCC=CS([O-])(=O)=O RUTSRVMUIGMTHJ-UHFFFAOYSA-M 0.000 description 3
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 108010001682 Dextranase Proteins 0.000 description 2
- 241000282320 Panthera leo Species 0.000 description 2
- WINXNKPZLFISPD-UHFFFAOYSA-M Saccharin sodium Chemical compound [Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 WINXNKPZLFISPD-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000008051 alkyl sulfates Chemical class 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- JOZKFWLRHCDGJA-UHFFFAOYSA-N citronellol acetate Chemical compound CC(=O)OCCC(C)CCC=C(C)C JOZKFWLRHCDGJA-UHFFFAOYSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- 235000019700 dicalcium phosphate Nutrition 0.000 description 2
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 2
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000002736 nonionic surfactant Substances 0.000 description 2
- 235000019477 peppermint oil Nutrition 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 150000003460 sulfonic acids Chemical class 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical group [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 description 1
- MHUNPSARLCGSPP-UHFFFAOYSA-N CC.OP(=O)OP(O)(O)=O Chemical compound CC.OP(=O)OP(O)(O)=O MHUNPSARLCGSPP-UHFFFAOYSA-N 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- JOZKFWLRHCDGJA-LLVKDONJSA-N Citronellyl acetate Natural products CC(=O)OCC[C@H](C)CCC=C(C)C JOZKFWLRHCDGJA-LLVKDONJSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 208000006558 Dental Calculus Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- AOMUHOFOVNGZAN-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)dodecanamide Chemical compound CCCCCCCCCCCC(=O)N(CCO)CCO AOMUHOFOVNGZAN-UHFFFAOYSA-N 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 125000004442 acylamino group Chemical group 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 1
- 229940088601 alpha-terpineol Drugs 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000000595 bitter masking effect Effects 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- XAAHAAMILDNBPS-UHFFFAOYSA-L calcium hydrogenphosphate dihydrate Chemical compound O.O.[Ca+2].OP([O-])([O-])=O XAAHAAMILDNBPS-UHFFFAOYSA-L 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 239000010630 cinnamon oil Substances 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 239000001524 citrus aurantium oil Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000010636 coriander oil Substances 0.000 description 1
- 229910002026 crystalline silica Inorganic materials 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 108010000165 exo-1,3-alpha-glucanase Proteins 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 239000010656 jasmine oil Substances 0.000 description 1
- ZNJFBWYDHIGLCU-HWKXXFMVSA-N jasmonic acid Chemical compound CC\C=C/C[C@@H]1[C@@H](CC(O)=O)CCC1=O ZNJFBWYDHIGLCU-HWKXXFMVSA-N 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 229940031957 lauric acid diethanolamide Drugs 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 229910000400 magnesium phosphate tribasic Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- YCWSUKQGVSGXJO-NTUHNPAUSA-N nifuroxazide Chemical group C1=CC(O)=CC=C1C(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 YCWSUKQGVSGXJO-NTUHNPAUSA-N 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 229910001631 strontium chloride Inorganic materials 0.000 description 1
- AHBGXTDRMVNFER-UHFFFAOYSA-L strontium dichloride Chemical compound [Cl-].[Cl-].[Sr+2] AHBGXTDRMVNFER-UHFFFAOYSA-L 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000008054 sulfonate salts Chemical class 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 229920000247 superabsorbent polymer Polymers 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- YUOWTJMRMWQJDA-UHFFFAOYSA-J tin(iv) fluoride Chemical compound [F-].[F-].[F-].[F-].[Sn+4] YUOWTJMRMWQJDA-UHFFFAOYSA-J 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- VXYADVIJALMOEQ-UHFFFAOYSA-K tris(lactato)aluminium Chemical compound CC(O)C(=O)O[Al](OC(=O)C(C)O)OC(=O)C(C)O VXYADVIJALMOEQ-UHFFFAOYSA-K 0.000 description 1
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 229940117960 vanillin Drugs 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 239000011746 zinc citrate Substances 0.000 description 1
- 229940068475 zinc citrate Drugs 0.000 description 1
- 235000006076 zinc citrate Nutrition 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- GFQYVLUOOAAOGM-UHFFFAOYSA-N zirconium(iv) silicate Chemical compound [Zr+4].[O-][Si]([O-])([O-])[O-] GFQYVLUOOAAOGM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/602—Glycosides, e.g. rutin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Emergency Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
α-올레핀술폰산염의 고미를 개선하고, 맛이 좋은 사용감을 부여하는 고미 개선제 및 이것을 함유하는 구강용 조성물을 제공한다. (A) α-올레핀술폰산염, (B) 글리시리진산 또는 그의 염, 및 (C) 리날로올옥시드, 시스-3-헥센올, 메틸디히드로자스모네이트, 리날로올, 리날릴아세테이트, 제라니올 및 메틸자스모네이트로부터 선택되는 1종 이상을 함유하는 구강용 조성물, 및 상기 (B) 및 (C) 성분을 함유하는, (A) 성분 함유의 구강용 조성물용으로서 적합하게 배합할 수 있는 (A) 성분의 고미 개선제.A bitter taste improving agent that improves the bitter taste of α-olefin sulfonate and imparts a pleasant feeling of use, and an oral composition containing the same. (A) α-olefin sulfonate, (B) glycyrrhizinic acid or a salt thereof, and (C) linalool oxide, cis-3-hexenol, methyldihydrojasmonate, linalool, linalyl acetate, agent An oral composition containing at least one selected from raniol and methyl jasmine, and an oral composition containing the component (A), containing the components (B) and (C), can be suitably blended. The bitter taste improver of the component (A).
Description
본 발명은, α-올레핀술폰산염의 고미를 개선하고, 맛이 좋은 사용감을 부여하는 고미 개선제 및 이것을 함유하는 구강용 조성물에 관한 것이다.The present invention relates to a bitter taste improving agent that improves the bitter taste of α-olefin sulfonate and imparts a pleasant feeling of use, and an oral composition containing the same.
음이온성 계면 활성제인 테트라데센술폰산나트륨 등의 α-올레핀술폰산염은, 구강 바이오 필름 제거 작용이 있는 것이 공지되어 있지만, 그의 작용 효과가 충분하지는 않고, 또한 효과 향상을 위해 구강용 조성물로의 배합량을 증가시키면, 그 자체에 의한 고미에 의해 맛이 나빠지고, 사용감이 저하된다는 과제가 있었다.It is known that α-olefin sulfonates such as sodium tetradecenesulfonate, which are anionic surfactants, have an oral biofilm removal effect, but their effect is not sufficient, and in order to improve the effect, When it is increased, there is a problem that the taste deteriorates due to bitterness by itself and the feeling of use decreases.
α-올레핀술폰산염에 아실아미노산염, 아르기닌, 덱스트라나아제 등을 병용하여, 자극이나 고미가 느껴지지 않는 구강 바이오 필름 제거제 및 이것을 배합한 구강용 조성물은, 특허문헌 1, 2(일본 특허 제6007781호 공보, 일본 특허 공개 제2015-20970호 공보)에 제안되어 있다.An oral biofilm remover that does not feel irritation or bitterness by using an acylamino acid salt, arginine, dextranase, etc. in combination with α-olefin sulfonate, and an oral composition containing the same are disclosed in Patent Documents 1 and 2 (Japanese Patent 6007781, Japanese Patent Laid-Open No. 2015-20970).
또한, 구강용 조성물에 있어서의 α-올레핀술폰산염에 의한 고미의 개선에, 향료를 응용한 기술로서, 페파민트유와 특정한 락톤 및 알데히드를 병용하면, α-올레핀술폰산염에 의한 고미를 사용 후에도 지속적으로 억제할 수 있는 것이, 특허문헌 3(국제 공개 제2017/094582호)에 제안되어 있다.In addition, as a technology that applies flavoring to the improvement of bitterness by α-olefin sulfonate in oral compositions, if peppermint oil and specific lactones and aldehydes are used in combination, the bitter taste by α-olefin sulfonate is continued even after use. What can be suppressed is proposed in Patent Document 3 (International Publication No. 2017/094582).
본 발명은 상기 사정을 감안하여 이루어진 것이며, α-올레핀술폰산염의 고미를 개선하고, 맛이 좋은 사용감을 부여하는 새로운 고미 개선제 및 이것을 함유하는 구강용 조성물을 제공하는 것을 목적으로 한다.The present invention has been made in view of the above circumstances, and an object of the present invention is to provide a new bitter taste improving agent that improves the bitter taste of α-olefin sulfonate and gives a pleasant feeling of use, and an oral composition containing the same.
본 발명자들은 상기 목적을 달성하기 위해 예의 검토를 행한 결과, α-올레핀술폰산염에, 글리시리진산 또는 그의 염과 특정한 향료 성분을 병용하고, 이들을 조합하여 배합하면, α-올레핀술폰산염의 고미를 개선할 수 있고, 따라서 상기 3 성분을 조합하여 구강용 조성물에 배합함으로써, α-올레핀술폰산염의 고미를 개선하고, 맛이 좋은 사용감을 부여할 수 있음을 지견하여, 본 발명을 이루기에 이르렀다.The inventors of the present invention have conducted extensive research in order to achieve the above object. As a result, glycyrrhizinic acid or a salt thereof and a specific fragrance component are used in combination with the α-olefin sulfonic acid salt, and when these are combined and blended, the bitter taste of the α-olefin sulfonate can be improved. Therefore, by combining the above three components and blending into an oral composition, it was discovered that the bitterness of the α-olefin sulfonate can be improved and a pleasant feeling of use can be provided, and the present invention has been achieved.
즉, 본 발명에 따르면, (A) α-올레핀술폰산염 함유의 구강용 조성물에, (B) 글리시리진산 또는 그의 염과, (C) 리날로올옥시드, 시스-3-헥센올, 메틸디히드로자스모네이트, 리날로올, 리날릴아세테이트, 제라니올 및 메틸자스모네이트로부터 선택되는 1종 이상의 향료 성분을 배합함으로써, (A) 성분에 의한 고미를 개선하고, 맛이 좋은 사용감을 얻을 수 있었다. 이 경우, (A) 성분에 (B) 성분을 조합해도 (A) 성분의 고미는 억제되지 않고, 또한 (A) 성분에 (C) 성분을 조합해도 (A) 성분의 고미는 억제되지 않았지만, (B) 및 (C) 성분을 병용하면, 의외로, 양자가 상승적으로 작용하여 (A) 성분의 고미가 마스킹되고 억제되어, 맛이 개선된다는 현저한 작용 효과를 발휘하였다.That is, according to the present invention, (A) an oral composition containing an α-olefin sulfonate, (B) glycyrrhizinic acid or a salt thereof, (C) linalooloxide, cis-3-hexenol, methyldihydro By blending one or more flavoring ingredients selected from jasmonate, linalool, linalyl acetate, geraniol and methyl jasmonate, the taste of the component (A) can be improved and a pleasant feeling of use can be obtained. there was. In this case, even if component (B) is combined with component (A), the bitter taste of component (A) is not suppressed, and even when component (C) is combined with component (A), bitter taste of component (A) is not suppressed, When the components (B) and (C) are used in combination, unexpectedly, both act synergistically, masking and suppressing the bitterness of the component (A), thereby exhibiting a remarkable effect of improving the taste.
또한, (B) 성분은 고감미도의 감미제로서 알려져 있고, 특히 구강용 조성물에 배합하면 고감미도 감미제에 특유의 느끼한 감미나 목구멍에 느껴지는 독특한 감미가 맛이 나쁨으로 남는 경우가 있었지만(특허문헌 4; 일본 특허 제5825093호 공보), (B) 및 (C) 성분을 병용하면, (B) 성분 특유의 불쾌한 감미가 느껴지지 않고 맛이 좋아지고, 또한 (A) 성분이 증량되어도 고미를 개선하여, 좋은 맛을 부여할 수 있었다.In addition, the component (B) is known as a sweetener having a high degree of sweetness, and in particular, when blended into an oral composition, the sweetness peculiar to the high-sweetness sweetener and the unique sweetness felt in the throat sometimes remain in bad taste (Patent Document 4; When the components (B) and (C) are used in combination, the taste improves without feeling the unpleasant sweetness peculiar to the component (B), and the bitterness is improved even when the component (A) is increased, It could give it a good taste.
본 발명의 작용 효과는, (A) 성분에 (B) 및 (C) 성분을 조합함으로써 얻어지는 특이하면서 현저한 것이다. 후술하는 비교예에 나타내는 바와 같이, 구강용 조성물이 (A) 성분을 함유하고, (B) 및 (C) 성분의 어느 것을 함유하지 않으면, 고미 없음이 떨어지고(×, 비교예 1, 2), 또한 (B) 성분을 함유하지 않으면, 감미제의 사카린나트륨의 함유량이 증량되어도 고미 없음이 떨어졌다(×, 비교예 3). 이에 비해, 실시예에 나타내는 본 발명의 (A), (B) 및 (C) 성분을 함유하는 구강용 조성물은, 고미 없음이 ○ 또는 ◎이며, 모두 고미가 개선되어 좋은 맛이었다.The effect of the present invention is unique and remarkable obtained by combining the components (B) and (C) with the component (A). As shown in the comparative examples described later, when the composition for oral cavity contains the component (A) and does not contain any of the components (B) and (C), the tastelessness is inferior (×, Comparative Examples 1 and 2), In addition, when the component (B) was not contained, even if the content of sodium saccharin in the sweetener was increased, the tastelessness was inferior (x, Comparative Example 3). On the other hand, the composition for oral cavity containing the components (A), (B) and (C) of the present invention shown in the examples had no bitterness of ◯ or ⊚, all of which improved bitterness and had good taste.
따라서, 본 발명은, 하기 구강용 조성물 및 α-올레핀술폰산염의 고미 개선제를 제공한다.Accordingly, the present invention provides the following oral composition and an agent for improving taste of the α-olefin sulfonate.
[1][One]
(A) α-올레핀술폰산염,(A) α-olefin sulfonate,
(B) 글리시리진산 또는 그의 염, 및(B) glycyrrhizic acid or a salt thereof, and
(C) 리날로올옥시드, 시스-3-헥센올, 메틸디히드로자스모네이트, 리날로올, 리날릴아세테이트, 제라니올 및 메틸자스모네이트로부터 선택되는 1종 이상(C) at least one selected from linalool oxide, cis-3-hexenol, methyldihydrojasmonate, linalool, linalyl acetate, geraniol and methyljasmonate
을 함유하는 구강용 조성물.Oral composition containing.
[2][2]
(B) 성분이 글리시리진산, 글리시리진산디칼륨, 글리시리진산트리나트륨 및 글리시리진산모노암모늄으로부터 선택되는 1종 이상인, [1]에 기재된 구강용 조성물.The composition for oral cavity according to [1], wherein the component (B) is at least one selected from glycyrrhizic acid, dipotassium glycyrrhizate, trisodium glycyrrhizinate, and monoammonium glycyrrhizinate.
[3][3]
(A) 성분을 0.1 내지 2.5질량%, (B) 성분을 0.01 내지 0.25질량%, (C) 성분을 0.00001 내지 0.3질량% 함유하는, [1] 또는 [2]에 기재된 구강용 조성물.The oral composition according to [1] or [2], containing 0.1 to 2.5% by mass of the component (A), 0.01 to 0.25% by mass of the component (B), and 0.00001 to 0.3% by mass of the component (C).
[4][4]
(A)/(B)로 표시되는 질량비가 1 내지 50인, [1] 내지 [3] 중 어느 한 항에 기재된 구강용 조성물.The oral composition according to any one of [1] to [3], wherein the mass ratio represented by (A)/(B) is 1 to 50.
[5][5]
(A)/(C)로 표시되는 질량비가 1 내지 30,000인, [1] 내지 [4] 중 어느 한 항에 기재된 구강용 조성물.The oral composition according to any one of [1] to [4], wherein the mass ratio represented by (A)/(C) is 1 to 30,000.
[6][6]
(C) 성분이(C) component
(C-1) 리날로올옥시드, 시스-3-헥센올, 리날로올, 리날릴아세테이트,(C-1) linalool oxide, cis-3-hexenol, linalool, linalyl acetate,
(C-2) 메틸디히드로자스모네이트, 메틸자스모네이트,(C-2) methyl dihydro jasmonate, methyl jasmonate,
(C-3) 제라니올(C-3) Geraniol
의 각 군에서 각각 1종 이상 선택되는, 3종 이상의 혼합물인, [1] 내지 [5] 중 어느 한 항에 기재된 구강용 조성물.The oral composition according to any one of [1] to [5], which is a mixture of three or more selected from each group of one or more.
[7][7]
치마제 조성물인, [1] 내지 [6] 중 어느 한 항에 기재된 구강용 조성물.The oral composition according to any one of [1] to [6], which is a dentifrice composition.
[8][8]
(B) 글리시리진산 또는 그의 염, 및(B) glycyrrhizic acid or a salt thereof, and
(C) 리날로올옥시드, 시스-3-헥센올, 메틸디히드로자스모네이트, 리날로올, 리날릴아세테이트, 제라니올 및 메틸자스모네이트로부터 선택되는 1종 이상(C) at least one selected from linalool oxide, cis-3-hexenol, methyldihydrojasmonate, linalool, linalyl acetate, geraniol and methyljasmonate
을 함유하는, (A) α-올레핀술폰산염의 고미 개선제.(A) A bitter taste improving agent of an α-olefin sulfonate containing.
[9][9]
(A)/(B)가 질량비로서 1 내지 50인, [8]에 기재된 (A) α-올레핀술폰산염의 고미 개선제.The bitter taste improving agent of (A) α-olefin sulfonate according to [8], wherein (A)/(B) is 1 to 50 as a mass ratio.
[10][10]
(A)/(C)가 질량비로서 1 내지 30,000인, [8] 또는 [9]에 기재된 (A) α-올레핀술폰산염의 고미 개선제.The bitter taste improver of (A) α-olefin sulfonate according to [8] or [9], wherein (A)/(C) is 1 to 30,000 as a mass ratio.
[11][11]
(C) 성분이(C) component
(C-1) 리날로올옥시드, 시스-3-헥센올, 리날로올, 리날릴아세테이트,(C-1) linalool oxide, cis-3-hexenol, linalool, linalyl acetate,
(C-2) 메틸디히드로자스모네이트, 메틸자스모네이트,(C-2) methyl dihydro jasmonate, methyl jasmonate,
(C-3) 제라니올(C-3) Geraniol
의 각 군에서 각각 1종 이상 선택되는, 3종 이상의 혼합물인, [8] 내지 [10] 중 어느 한 항에 기재된 α-올레핀술폰산염의 고미 개선제.The bitter taste improving agent of the α-olefin sulfonate according to any one of [8] to [10], which is a mixture of three or more selected from each group of.
[12][12]
(A) α-올레핀술폰산염을 함유하는 구강용 조성물용인, [8] 내지 [11] 중 어느 한 항에 기재된 (A) α-올레핀술폰산염의 고미 개선제.(A) The bitter taste improver of (A) α-olefin sulfonate according to any one of [8] to [11], which is for an oral composition containing an α-olefin sulfonate.
본 발명에 따르면, α-올레핀술폰산염의 고미를 개선하고, 맛이 좋은 사용감을 부여하는 α-올레핀술폰산염의 고미 개선제 및 이것을 함유하는 구강용 조성물을 제공할 수 있다. 본 발명의 구강용 조성물은, α-올레핀술폰산염의 고미가 개선되는 점에서, α-올레핀술폰산염에 의해 만족스러운 구강 바이오 필름 제거 효과를 부여하는 것도 가능하다.According to the present invention, it is possible to provide an agent for improving the bitter taste of α-olefin sulfonate and providing a pleasant feeling of use, and an oral composition containing the same. The oral composition of the present invention can also impart a satisfactory oral biofilm removal effect by using the α-olefin sulfonate because the bitter taste of the α-olefin sulfonate is improved.
이하, 본 발명에 대하여 더욱 상세하게 설명한다. 본 발명의 구강용 조성물은, (A) α-올레핀술폰산염, (B) 글리시리진산 또는 그의 염, 및 (C) 특정한 향료 성분을 함유한다.Hereinafter, the present invention will be described in more detail. The composition for oral cavity of the present invention contains (A) α-olefin sulfonate, (B) glycyrrhizic acid or a salt thereof, and (C) a specific fragrance component.
이 경우, (B) 글리시리진산 또는 그의 염, 및 (C) 특정한 향료 성분이, (A) 성분의 고미 개선을 위한 유효 성분이며, 이들 유효 성분만을 포함하는 (A) 성분의 고미 개선제로서 사용할 수 있지만, 후술하는 바와 같은 상기 성분 이외의 기타 임의 성분을 더 배합하고, (A) 성분의 고미 개선의 유효 성분으로서 (B) 및 (C) 성분을 함유하는 구강용 조성물로 조제할 수 있다.In this case, (B) glycyrrhizinic acid or a salt thereof, and (C) a specific fragrance component are active ingredients for improving the bitter taste of the component (A), and can be used as a bitter taste improving agent for the component (A) containing only these active ingredients. However, other optional components other than the above-described components as described later may be further blended and prepared as an oral composition containing components (B) and (C) as active ingredients for improving bitterness of component (A).
(A) α-올레핀술폰산염으로서는, 탄소수가 14 내지 16인 α-올레핀술폰산의 나트륨, 칼륨 등의 알칼리 금속염을 사용할 수 있고, 바람직하게는 탄소수 14의 α-올레핀술폰산염, 특히 나트륨염(일반명; 테트라데센술폰산나트륨)이다. 이들은 구강용 조성물에 사용 가능한 시판품을 입수할 수 있고, 예를 들어 라이온·스페셜티·케미컬(주)제의 상품명 「K 리포란 PJ-400CJ」를 사용할 수 있다.(A) As the α-olefin sulfonic acid salt, alkali metal salts such as sodium and potassium of α-olefin sulfonic acid having 14 to 16 carbon atoms can be used, preferably α-olefin sulfonate having 14 carbon atoms, especially sodium salt (general Name; sodium tetradecenesulfonate). These can obtain a commercial item that can be used for an oral composition, and for example, a brand name "K Liporan PJ-400CJ" manufactured by Lion Specialty Chemical Co., Ltd. can be used.
본 발명에서는, (B) 및 (C) 성분을 병용하면, 이 병용계가 (A) 성분의 고미를 마스킹하여 억제하고, 고미 개선제로서 작용한다.In the present invention, when components (B) and (C) are used in combination, this combination system masks and suppresses the bitter taste of the component (A), and acts as a bitter taste improving agent.
(B) 글리시리진산 또는 그의 염은, 예를 들어 글리시리진산, 글리시리진산디칼륨, 글리시리진산트리나트륨, 글리시리진산모노암모늄 등을 들 수 있고, 이들 중 1종을 단독 또는 2종 이상을 병용하여 배합할 수 있다. 그 중에서도 글리시리진산디칼륨이 바람직하다.(B) glycyrrhizic acid or a salt thereof may include, for example, glycyrrhizinic acid, dipotassium glycyrrhizate, trisodium glycyrrhizate, monoammonium glycyrrhizate, etc., and one of these may be used alone or in combination of two or more. I can. Among them, dipotassium glycyrrhizate is preferable.
글리시리진산 또는 그의 염은 시판품을 사용할 수 있다. 예를 들어, 마루젠 세이야쿠(주)제의 외원규(의약부외품 원료 규격) 규격품의 글리시리진산디칼륨 등을 사용할 수 있다.Glycyrrhizic acid or a salt thereof can be used commercially. For example, it is possible to use dipotassium glycyrrhizinate of Maruzen Seiyaku Co., Ltd. manufactured by Oe Won-gyu (quasi-drug raw material standard) standard product.
(A) 성분과 (B) 성분의 양비를 나타내는 (A)/(B)는, 질량비로서 1 내지 50이 바람직하고, 보다 바람직하게는 1.5 내지 40, 특히 1.5 내지 15이다. 이 범위 내이면, 고미의 개선 효과가 보다 우수하고, 맛이 더 좋아진다.The mass ratio of (A)/(B) showing the amount ratio of the component (A) and the component (B) is preferably 1 to 50, more preferably 1.5 to 40, and particularly 1.5 to 15. Within this range, the effect of improving the bitter taste is more excellent, and the taste becomes better.
(C) 성분은 리날로올옥시드, 시스-3-헥센올, 메틸디히드로자스모네이트, 리날로올, 리날릴아세테이트, 제라니올 및 메틸자스모네이트로부터 선택되는 1종 이상의 향료 성분이다. 그 중에서도, 고미의 개선의 점에서, 특히 리날로올옥시드, 시스-3-헥센올, 메틸디히드로자스모네이트가 바람직하다. 이들은 1종 단독으로 사용해도, 효과 발현의 점에서 2종 이상, 또한 3종 이상을 병용해도 된다.The component (C) is at least one perfume component selected from linalool oxide, cis-3-hexenol, methyldihydrojasmonate, linalool, linalyl acetate, geraniol and methyljasmonate. Among them, linalooloxide, cis-3-hexenol, and methyldihydrojasmonate are particularly preferred from the viewpoint of improving the taste. These may be used alone or in combination of two or more, or three or more from the viewpoint of effect expression.
바람직하게는 2종 이상을 병용하고, 적어도Preferably, two or more types are used in combination, and at least
(C-1) 리날로올옥시드, 시스―3-헥센올, 리날로올 및 리날릴아세테이트로부터 선택되는 향료 성분(C-1) a fragrance component selected from linalool oxide, cis-3-hexenol, linalool, and linalyl acetate
을 함유하는 것이 바람직하다.It is preferable to contain.
보다 바람직하게는 3종 이상을 병용하고, 상기 (C-1)에 나타내는 향료 성분과,More preferably, three or more types are used in combination, and the perfume component shown in (C-1) above,
(C-2) 메틸디히드로자스모네이트 및 메틸자스모네이트로부터 선택되는 향료 성분과,(C-2) a fragrance component selected from methyl dihydro jasmonate and methyl jasmonate,
(C-3) 제라니올(C-3) Geraniol
을 조합하는 것이 바람직하고, 상기 (C-1), (C-2), (C-3)의 각 군에서 각각 1종 또는 그 이상을 선택하고, 이들 향료 성분을 혼합하여 사용할 수 있다.It is preferable to combine, and each one or more selected from each of the groups (C-1), (C-2), and (C-3) may be used by mixing these fragrance components.
(C) 성분으로서 구체적으로는, 리날로올옥시드(Linalool oxide), 시스-3-헥센올(cis-3-hexenol), 메틸디히드로자스모네이트(Methyl dihydro jasmonate), 리날로올(Linalool), 리날릴아세테이트(Linalyl acetate), 제라니올(Geraniol), 메틸자스모네이트(Methyl jasmonate)의 단일 향료 소재를 사용할 수 있다. 또한, 이들을 포함하는 정유, 예를 들어 라벤더유, 코리앤더유, 네롤리유(오렌지 플라워유), 장미유, 자스민유 등을 사용할 수도 있다. 이들은, 예를 들어 다카사 고료 고교(주), 다이요 고료(주), 소다 고료(주)제 등의 시판품을 사용할 수 있다.(C) Specifically, as a component, linalool oxide, cis-3-hexenol, methyl dihydro jasmonate, linalool , Linalyl acetate, Geraniol, and methyl jasmonate can be used as a single fragrance material. In addition, essential oils containing these, for example, lavender oil, coriander oil, neroli oil (orange flower oil), rose oil, jasmine oil, and the like may be used. These can use commercial items, such as Takasa Goryo High School Co., Ltd., Daiyo Goryo Co., Ltd., and Soda Goryo Co., Ltd. product, for example.
(A) 성분과 (C) 성분의 양비를 나타내는 (A)/(C)는, 질량비로서 1 내지 30,000이 바람직하고, 보다 바람직하게는 3 내지 3,000이다. 이 범위 내이면, 고미의 개선 효과가 보다 우수하고, 맛이 더 좋아진다.The mass ratio of (A)/(C) showing the amount ratio of the component (A) and the component (C) is preferably 1 to 30,000, more preferably 3 to 3,000. Within this range, the effect of improving the bitter taste is more excellent, and the taste becomes better.
또한, (B) 성분과 (C) 성분의 양비를 나타내는 (B)/(C)는, 질량비로서 0.1 내지 5,000이 바람직하고, 보다 바람직하게는 0.5 내지 500이다. 이 범위 내이면, 고미의 개선 효과가 더욱 우수하다.In addition, as for (B)/(C) showing the amount ratio of the component (B) and the component (C), the mass ratio is preferably 0.1 to 5,000, more preferably 0.5 to 500. Within this range, the effect of improving bitter taste is more excellent.
본 발명에서는, (A)/(B), (A)/(C)가 각각 질량비로서 상기 범위 내이며, 또한 (B)/(C)가 질량비로서 상기 범위 내이면, 고미의 개선 효과가 특히 우수하다.In the present invention, when (A)/(B) and (A)/(C) are each within the above range as a mass ratio, and (B)/(C) is within the above range as a mass ratio, the effect of improving bitterness is particularly great.
본 발명의 구강용 조성물은, (A), (B) 및 (C) 성분의 배합량이 각각 하기 범위 내인 것이 바람직하다.In the composition for oral cavity of the present invention, it is preferable that the amounts of the components (A), (B) and (C) are within the following ranges, respectively.
(A) α-올레핀술폰산염의 배합량은, 조성물 전체의 0.1 내지 2.5%(질량%, 이하 동일함)가 바람직하고, 보다 바람직하게는 0.1 내지 2%, 더욱 바람직하게는 0.2 내지 1%이다. 배합량이 0.1% 이상이면, 구강 바이오 필름을 분산, 제거하는 효과가 충분히 얻어진다. 배합량이 증가할수록 그 자체에 의한 고미가 강하게 발현되지만, 2.5% 이하이면, 그 자체에 의한 고미가 충분히 개선된다.(A) The blending amount of the α-olefin sulfonate salt is preferably 0.1 to 2.5% (the same applies hereinafter) of the whole composition, more preferably 0.1 to 2%, and still more preferably 0.2 to 1%. When the blending amount is 0.1% or more, the effect of dispersing and removing the oral biofilm is sufficiently obtained. As the blending amount increases, the bitter taste by itself is strongly expressed, but if it is 2.5% or less, the bitter taste by itself is sufficiently improved.
(B) 글리시리진산 또는 그의 염의 배합량은, 조성물 전체의 0.01 내지 0.25%가 바람직하고, 보다 바람직하게는 0.02 내지 0.2%이다. 배합량이 0.01% 이상이면, 고미의 마스킹 효과가 충분히 발휘된다. 0.25% 이하이면, 그 자체에 의한 독특한 감미의 발현이 충분히 방지되어 맛이 좋음이 유지된다.(B) The blending amount of glycyrrhizinic acid or its salt is preferably 0.01 to 0.25% of the total composition, and more preferably 0.02 to 0.2%. When the blending amount is 0.01% or more, a bitter masking effect is sufficiently exhibited. If it is 0.25% or less, the expression of unique sweetness by itself is sufficiently prevented, and good taste is maintained.
(C) 성분의 배합량은, 순분 환산으로 조성물 전체의 0.00001 내지 0.3%가 바람직하고, 보다 바람직하게는 0.0001 내지 0.1%이다. 배합량이 0.00001% 이상이면, 충분한 고미 억제 효과가 얻어진다. 0.3% 이하이면, 그 자체에서 유래하는 향기나 맛이 너무 강하게 발현되지 않아, 충분히 좋은 사용감이 얻어진다.The blending amount of the component (C) is preferably 0.00001 to 0.3%, more preferably 0.0001 to 0.1% of the whole composition in terms of pure powder. When the blending amount is 0.00001% or more, a sufficient bitterness suppression effect is obtained. If it is 0.3% or less, the fragrance and taste derived from itself are not expressed too strongly, and a sufficiently good feeling of use is obtained.
본 발명의 구강용 조성물은 고체, 액체 등의 액상, 겔상, 페이스트상, 검상 등의 형태로 할 수 있고, 크림 치마, 액체 치마, 액상 치마, 윤제(潤製) 치마 등의 치마제, 구강 세척제, 마우스 워시, 트로키제, 츄잉검 등의 다양한 제형으로 하는 것이 가능하고, 그의 제조 방법도 제형에 따른 통상의 방법을 채용할 수 있지만, 특히 크림 치마 등의 치마제 조성물이 바람직하다. 이 경우, 조성물의 목적, 제형 등에 따라서 상술한 성분 이외에도 적당한 기타 임의 성분을 배합할 수 있다. 예를 들어, 치마제 조성물의 경우에는, 연마제, 점조제, 점결제, (A) 성분 이외의 계면 활성제, 필요에 따라서, (B) 성분 이외의 감미제, 방부제, 색소, (C) 성분 이외의 향료, 유효 성분 등을 더 배합할 수 있고, 이들 성분과 물을 혼합하여 제조할 수 있다.The oral composition of the present invention can be in the form of a solid, liquid such as a liquid, gel, paste, gum, etc., and a cream skirt, a liquid skirt, a liquid skirt, a skirt agent such as a luster skirt, and an oral cleaner , Mouth wash, troche, chewing gum, etc. It is possible to use a variety of formulations, the production method can also employ a conventional method according to the formulation, in particular, a skirt composition such as a cream skirt is preferred. In this case, in addition to the above-described components, other suitable optional components may be blended depending on the purpose of the composition, formulation, and the like. For example, in the case of a dentifrice composition, an abrasive, a viscous agent, a caking agent, a surfactant other than the component (A), if necessary, a sweetening agent other than the component (B), a preservative, a colorant, and a fragrance other than the component (C) , Active ingredients and the like may be further blended, and these ingredients and water may be mixed to prepare them.
연마제는 결정성 실리카, 비정질성 실리카, 실리카겔, 알루미노실리케이트 등의 실리카계 연마제, 인산수소칼슘무수화물, 인산수소칼슘2수화물, 제3인산칼슘, 제4인산칼슘, 피로인산칼슘 등의 인산칼슘계 연마제, 제3인산마그네슘, 탄산칼슘, 수산화알루미늄, 알루미나, 탄산마그네슘, 제올라이트, 규산지르코늄, 하이드록시아파타이트, 합성 수지계 연마제를 들 수 있다. 연마제의 배합량은 통상 조성물 전체의 5 내지 70%, 특히 10 내지 50%이다.Abrasives include silica-based abrasives such as crystalline silica, amorphous silica, silica gel, and aluminosilicate, calcium phosphate such as calcium hydrogen phosphate anhydride, calcium hydrogen phosphate dihydrate, calcium phosphate tribasic, calcium phosphate, and calcium pyrophosphate. Type abrasives, tertiary magnesium phosphate, calcium carbonate, aluminum hydroxide, alumina, magnesium carbonate, zeolite, zirconium silicate, hydroxyapatite, and synthetic resin type abrasives. The blending amount of the abrasive is usually 5 to 70%, particularly 10 to 50% of the total composition.
점결제는, 예를 들어 크산탄검 등의 검류, 카르복시메틸셀룰로오스나트륨 등의 셀룰로오스 유도체, 카라기난 등의 직쇄 황 함유 다당류, 폴리아크릴산나트륨 등의 고흡수성 고분자 물질을 들 수 있다. 점결제의 배합량은, 통상 조성물 전체의 0 내지 10%, 특히 0.1 내지 5%이다.Examples of the binder include gums such as xanthan gum, cellulose derivatives such as sodium carboxymethylcellulose, linear sulfur-containing polysaccharides such as carrageenan, and superabsorbent polymer substances such as sodium polyacrylate. The blending amount of the caking agent is usually 0 to 10%, particularly 0.1 to 5% of the total composition.
점조제는 소르비트, 자일리톨, 에리트리톨 등의 당알코올, 프로필렌글리콜, 부틸렌글리콜, 글리세린, 폴리에틸렌글리콜 등의 다가 알코올을 들 수 있다. 점조제의 배합량은 통상적으로 조성물 전체의 0 내지 70%, 특히 3 내지 50%이다.Examples of the viscosity aid include sugar alcohols such as sorbit, xylitol, and erythritol, polyhydric alcohols such as propylene glycol, butylene glycol, glycerin and polyethylene glycol. The blending amount of the viscous agent is usually 0 to 70%, particularly 3 to 50% of the total composition.
계면 활성제는 구강용 조성물용으로서 공지된 계면 활성제를 사용할 수 있고, 예를 들어 (A) 성분 이외의 음이온성 계면 활성제, 비이온성 계면 활성제를 들 수 있다.As the surfactant, known surfactants for oral compositions can be used, and examples thereof include anionic surfactants and nonionic surfactants other than the component (A).
(A) 성분 이외의 음이온성 계면 활성제는, 예를 들어 라우릴황산나트륨 등의 알킬황산염을 들 수 있다.Examples of anionic surfactants other than the component (A) include alkyl sulfates such as sodium lauryl sulfate.
비이온성 계면 활성제는, 예를 들어 자당지방산에스테르 등의 당지방산에스테르, 당알코올지방산에스테르, 소르비탄지방산에스테르, 글리세린지방산에스테르, 폴리글리세린지방산에스테르, 폴리옥시에틸렌소르비탄지방산에스테르나, 폴리옥시에틸렌 경화 피마자유 등의 폴리옥시에틸렌지방산에스테르, 폴리옥시에틸렌라우릴에테르 등의 폴리옥시에틸렌 고급 알코올에테르, 라우르산디에탄올아미드 등의 지방산 알칸올아미드를 들 수 있다.Nonionic surfactants include, for example, sugar fatty acid esters such as sucrose fatty acid esters, sugar alcohol fatty acid esters, sorbitan fatty acid esters, glycerin fatty acid esters, polyglycerol fatty acid esters, polyoxyethylene sorbitan fatty acid esters, and polyoxyethylene cured Polyoxyethylene fatty acid esters such as castor oil, polyoxyethylene higher alcohol ethers such as polyoxyethylene lauryl ether, and fatty acid alkanolamides such as lauric acid diethanolamide.
본 발명에서는, (A) 성분 이외에도 음이온성 계면 활성제로서 알킬황산염이나 글리세린지방산에스테르의 황산염을 조성물 전체에 대하여 10% 이하, 특히 5% 이하, 특히 3% 이하로 첨가하여, 발포성을 높여도 된다. 또한, 이들 임의의 계면 활성제의 배합량은, 본 발명의 효과를 방해하지 않는 범위이면 되고, 계면 활성제의 총 배합량((A) 성분의 배합량과 임의의 계면 활성제의 배합량의 합계량)은 조성물 전체의 0.1 내지 10%, 특히 0.2 내지 5%가 바람직하다.In the present invention, in addition to the component (A), as an anionic surfactant, a sulfate salt of an alkyl sulfate or a glycerin fatty acid ester may be added in an amount of 10% or less, particularly 5% or less, and particularly 3% or less with respect to the entire composition to increase foamability. In addition, the blending amount of these optional surfactants should be within a range that does not interfere with the effect of the present invention, and the total blending amount of the surfactant (the total amount of the blending amount of the component (A) and the blending amount of the optional surfactant) is 0.1 To 10%, particularly preferably 0.2 to 5%.
감미제는 사카린나트륨 등을 들 수 있다. 방부제는 벤조산나트륨 등의 벤조산 또는 그의 염, 메틸파라벤, 에틸파라벤, 부틸파라벤 등의 파라옥시벤조산에스테르를 들 수 있다.Sweetening agents include sodium saccharin and the like. Preservatives include benzoic acid such as sodium benzoate or salts thereof, and paraoxybenzoic acid esters such as methylparaben, ethylparaben, and butylparaben.
색소는 식용 색소인 브릴리언트 블루, 타트라진 등이나, 안료의 산화티타늄을 들 수 있다.The pigments include food colorings such as brilliant blue and tatrazine, and pigments of titanium oxide.
향료는 구강용으로서 일반적으로 사용할 수 있는, (C) 성분 이외의 향료 성분을 배합해도 된다. 예를 들어 멘톨, 아네톨, 카르본, 유게놀, 리모넨, n-데실알코올, 시트로넬롤, α-테르피네올, 시트로넬릴아세테이트, 시네올, 바닐린, 티몰, 스피아민트유, 페파민트유, 레몬유, 오렌지유, 세이지유, 로즈마리유, 계피유, 피멘토유, 계엽유, 차조기유, 동록유, 정자유, 유칼립투스유 등의 향료 소재를 들 수 있다.The fragrance may contain fragrance components other than the component (C), which can be generally used for oral use. For example, menthol, anetol, carbon, eugenol, limonene, n-decyl alcohol, citronellol, α-terpineol, citronellyl acetate, cineol, vanillin, thymol, spearmint oil, peppermint oil, And flavoring materials such as lemon oil, orange oil, sage oil, rosemary oil, cinnamon oil, pimento oil, chicken leaf oil, perilla oil, dong green oil, sperm oil, and eucalyptus oil.
상기 향료 소재의 배합량은 조성물 전체의 0.000001 내지 2%이면 되고, 또한 상기 향료 소재를 사용한 부향용 향료의 배합량은, 조성물 전체의 0.1 내지 2%가 바람직하다.The blending amount of the fragrance material is preferably 0.000001 to 2% of the total composition, and the blending amount of the fragrance fragrance using the fragrance material is preferably 0.1 to 2% of the total composition.
또한, 향료 소재가 (C) 성분을 포함하는 경우, 그 향료 소재는 상기 (C) 성분의 배합량을 충족하는 범위 내에서 사용할 수 있다.In addition, when the fragrance material contains the component (C), the fragrance material can be used within a range satisfying the blending amount of the component (C).
유효 성분은, 구강용으로서 공지된 약용 성분, 예를 들어 클로로헥시딘, 트리클로산, 이소프로필메틸페놀, 염화세틸피리디늄, 염화벤제토늄, 염화벤잘코늄, 글루콘산아연, 시트르산아연 등의 살균 또는 항균제; 에탄히드록시디포스포네이트 등의 치석 예방제; 트라넥삼산, 알란토인클로르히드록시알루미늄 등의 항염증제; 히드록시에틸셀룰로오스디메틸디아릴암모늄클로라이드 등의 코팅제; 덱스트라나아제, 무타나아제, 염화리소자임 등의 효소제; 아스코르브산, 아세트산토코페롤 등의 비타민류; 염화나트륨 등의 수렴제; 락트산알루미늄, 염화스트론튬, 질산칼륨 등의 지각 과민 억제제; 불화나트륨, 모노플루오로인산나트륨, 불화제1주석 등의 불화물을 들 수 있다. 이들은 약제학적으로 허용할 수 있는 범위에서, 유효량으로 사용할 수 있다.The active ingredient is a medicinal ingredient known for oral use, such as sterilization of chlorohexidine, triclosan, isopropylmethylphenol, cetylpyridinium chloride, benzethonium chloride, benzalkonium chloride, zinc gluconate, zinc citrate, etc. Antibacterial agents; Tartar preventing agents such as ethane hydroxydiphosphonate; Anti-inflammatory agents such as tranexamic acid and allantoinchlorhydroxyaluminum; Coating agents such as hydroxyethyl cellulose dimethyl diaryl ammonium chloride; Enzyme agents such as dextranase, mutanase, and lysozyme chloride; Vitamins such as ascorbic acid and tocopherol acetate; Astringents such as sodium chloride; Hypersensitivity inhibitors such as aluminum lactate, strontium chloride, and potassium nitrate; And fluorides such as sodium fluoride, sodium monofluorophosphate, and tin fluoride. These can be used in an effective amount within a pharmaceutically acceptable range.
실시예Example
이하, 실시예 및 비교예를 나타내어, 본 발명을 구체적으로 설명하지만, 본 발명이 하기 실시예에 제한되는 것은 아니다. 또한, 하기 예에 있어서 %는 특별히 언급이 없는 한 모두 질량%를 나타낸다.Hereinafter, examples and comparative examples are shown to specifically describe the present invention, but the present invention is not limited to the following examples. In addition, in the following examples, all represent% by mass unless otherwise specified.
[실시예, 비교예][Examples, Comparative Examples]
표 1 내지 4에 나타내는 조성의 치마제 조성물(크림 치마)을 통상의 방법에 의해 조제하고, 하기 방법으로 평가하였다. 결과를 표에 병기하였다.The skirt composition (cream skirt) of the composition shown in Tables 1 to 4 was prepared by a conventional method, and evaluated by the following method. The results are listed in the table.
사용 시의 고미(고미 없음)의 평가 방법Evaluation method of bitterness (no bitterness) in use
피험자로서 전문가 패널리스트 10명을 사용한 관능 시험에 의해 평가하였다. 치마제 조성물을 칫솔 위에 1g 취하고, 평소와 마찬가지의 방법으로 3분간 브러싱을 행하여, 사용 중에 느껴진 고미에 대하여, 이하의 평점 기준으로 평가하였다.It was evaluated by a sensory test using 10 expert panelists as subjects. 1 g of the dentifrice composition was taken on a toothbrush, brushed for 3 minutes in the same manner as usual, and the bitter taste felt during use was evaluated based on the following rating criteria.
평점 기준Rating criteria
4점: 고미가 전혀 없다4 points: no taste at all
3점: 고미가 거의 없다3 points: almost no taste
2점: 고미가 약간 있다2 points: slightly bitter
1점: 고미가 있다1 point: taste good
10명의 평점 결과를 평균하여, 하기 평가 기준으로 판정하였다. ◎ 및 ○의 평가가 확보되는 것을, 고미가 없는 치마제 조성물이라고 판단하였다.The score results of 10 people were averaged, and it was determined by the following evaluation criteria. It was judged that the evaluation of ◎ and ○ was ensured as a dentifrice composition without bitterness.
평가 기준Evaluation standard
◎: 3.5점 이상 4.0점 이하◎: 3.5 or more and 4.0 or less
○: 3.0점 이상 3.5점 미만○: 3.0 or more and less than 3.5
△: 2.0점 이상 3.0점 미만△: 2.0 points or more and less than 3.0 points
×: 2.0점 미만×: less than 2.0 points
사용 원료의 상세를 하기에 나타낸다.Details of the raw materials used are shown below.
(A) 테트라데센술폰산나트륨; 상품명 K 리포란 PJ-400CJ, 라이온·스페셜티·케미컬(주)제(A) sodium tetradecenesulfonate; Brand name K Liporan PJ-400CJ, manufactured by Lion Specialty Chemical Co., Ltd.
(B) 글리시리진산디칼륨; 마루젠 세이야쿠(주)제의 외원규 규격품(B) dipotassium glycyrrhizinate; Maruzen Seiyaku Co., Ltd. standard product
(C) 리날로올옥시드; 다이요 고료(주)(C) linalooloxide; Daiyo Goryo Co., Ltd.
시스-3-헥센올; 신에쯔 가가꾸 고교(주)제Cis-3-hexenol; Shin-Etsu Chemical High School Co., Ltd.
메틸디히드로자스모네이트; 다카사 고료 고교(주)제Methyl dihydro jasmonate; Takasa Goryo High School Co., Ltd.
리날로올; 다카사 고료 고교(주)제Linalool; Takasa Goryo High School Co., Ltd.
리날릴아세테이트; 다카사 고료 고교(주)제Linalyl acetate; Takasa Goryo High School Co., Ltd.
제라니올; 다카사 고료 고교(주)제Geraniol; Takasa Goryo High School Co., Ltd.
메틸자스모네이트; 소다 고료(주)제Methyl jasmonate; Soda Goryo Co., Ltd.
Claims (12)
(B) 글리시리진산 또는 그의 염, 및
(C) 리날로올옥시드, 시스-3-헥센올, 메틸디히드로자스모네이트, 리날로올, 리날릴아세테이트, 제라니올 및 메틸자스모네이트로부터 선택되는 1종 이상
을 함유하는 구강용 조성물.(A) α-olefin sulfonate,
(B) glycyrrhizic acid or a salt thereof, and
(C) at least one selected from linalool oxide, cis-3-hexenol, methyldihydrojasmonate, linalool, linalyl acetate, geraniol and methyljasmonate
Oral composition containing.
(C-1) 리날로올옥시드, 시스-3-헥센올, 리날로올, 리날릴아세테이트,
(C-2) 메틸디히드로자스모네이트, 메틸자스모네이트,
(C-3) 제라니올
의 각 군에서 각각 1종 이상 선택되는, 3종 이상의 혼합물인 구강용 조성물.The method according to any one of claims 1 to 5, wherein component (C) is
(C-1) linalool oxide, cis-3-hexenol, linalool, linalyl acetate,
(C-2) methyl dihydro jasmonate, methyl jasmonate,
(C-3) Geraniol
Oral composition of a mixture of three or more, each selected from each group of at least one.
(C) 리날로올옥시드, 시스-3-헥센올, 메틸디히드로자스모네이트, 리날로올, 리날릴아세테이트, 제라니올 및 메틸자스모네이트로부터 선택되는 1종 이상
을 함유하는 (A) α-올레핀술폰산염의 고미 개선제.(B) glycyrrhizic acid or a salt thereof, and
(C) at least one selected from linalool oxide, cis-3-hexenol, methyldihydrojasmonate, linalool, linalyl acetate, geraniol and methyljasmonate
(A) A bitter taste improving agent of α-olefin sulfonate containing.
(C-1) 리날로올옥시드, 시스-3-헥센올, 리날로올, 리날릴아세테이트,
(C-2) 메틸디히드로자스모네이트, 메틸자스모네이트,
(C-3) 제라니올
의 각 군에서 각각 1종 이상 선택되는, 3종 이상의 혼합물인 α-올레핀술폰산염의 고미 개선제.The method according to any one of claims 8 to 10, wherein component (C) is
(C-1) linalool oxide, cis-3-hexenol, linalool, linalyl acetate,
(C-2) methyl dihydro jasmonate, methyl jasmonate,
(C-3) Geraniol
A bitter taste improver of α-olefin sulfonate, which is a mixture of three or more, each selected from each group of at least one.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018073609 | 2018-04-06 | ||
JPJP-P-2018-073609 | 2018-04-06 | ||
PCT/JP2019/013611 WO2019194068A1 (en) | 2018-04-06 | 2019-03-28 | ORAL COMPOSITION, AND BITTERNESS AMELIORATION AGENT FOR α-OLEFIN SULFONATES |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20200141442A true KR20200141442A (en) | 2020-12-18 |
Family
ID=68100441
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020207027262A KR20200141442A (en) | 2018-04-06 | 2019-03-28 | Oral composition and bitter taste improver of α-olefin sulfonate |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP7255587B2 (en) |
KR (1) | KR20200141442A (en) |
CN (1) | CN111902125B (en) |
WO (1) | WO2019194068A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7331182B2 (en) * | 2017-10-12 | 2023-08-22 | サンスター株式会社 | Silica-containing oral composition |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5825093B2 (en) | 1975-06-23 | 1983-05-25 | 住友ベークライト株式会社 | phenol |
JPS607781B2 (en) | 1976-05-18 | 1985-02-27 | 石原産業株式会社 | Photosensitive materials for electrophotography |
JP2015020970A (en) | 2013-07-18 | 2015-02-02 | ライオン株式会社 | Oral biofilm removing agent and composition for oromucosal application |
WO2017094582A1 (en) | 2015-11-30 | 2017-06-08 | ライオン株式会社 | Oral composition |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62234010A (en) * | 1986-04-03 | 1987-10-14 | Lion Corp | Composition for oral cavity application |
JPH01165516A (en) * | 1987-12-23 | 1989-06-29 | Lion Corp | Composition for oral cavity |
JPH09132517A (en) * | 1995-11-09 | 1997-05-20 | Lion Corp | Composition for oral cavity |
JP2001064136A (en) | 1999-08-26 | 2001-03-13 | Kao Corp | Composition for oral cavity |
JP5057646B2 (en) * | 2004-12-10 | 2012-10-24 | 株式会社ノエビア | Tyrosinase activity inhibitor and topical skin preparation |
JP5041761B2 (en) * | 2005-08-10 | 2012-10-03 | ロート製薬株式会社 | Ocular mucosa application |
JP4893124B2 (en) | 2006-06-27 | 2012-03-07 | ライオン株式会社 | Liquid oral composition |
JP5874383B2 (en) | 2011-12-21 | 2016-03-02 | ライオン株式会社 | Oral composition |
JP6007781B2 (en) | 2011-12-26 | 2016-10-12 | ライオン株式会社 | Oral composition and oral biofilm remover |
DE102013204088A1 (en) * | 2013-03-11 | 2014-09-11 | Beiersdorf Ag | Active ingredient combinations of alkylamidothiazoles and one or more cosmetically or dermatologically relevant fragrances |
JP6451392B2 (en) | 2015-02-19 | 2019-01-16 | ライオン株式会社 | Oral composition |
-
2019
- 2019-03-28 KR KR1020207027262A patent/KR20200141442A/en not_active Application Discontinuation
- 2019-03-28 JP JP2020512201A patent/JP7255587B2/en active Active
- 2019-03-28 CN CN201980021567.8A patent/CN111902125B/en active Active
- 2019-03-28 WO PCT/JP2019/013611 patent/WO2019194068A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5825093B2 (en) | 1975-06-23 | 1983-05-25 | 住友ベークライト株式会社 | phenol |
JPS607781B2 (en) | 1976-05-18 | 1985-02-27 | 石原産業株式会社 | Photosensitive materials for electrophotography |
JP2015020970A (en) | 2013-07-18 | 2015-02-02 | ライオン株式会社 | Oral biofilm removing agent and composition for oromucosal application |
WO2017094582A1 (en) | 2015-11-30 | 2017-06-08 | ライオン株式会社 | Oral composition |
Also Published As
Publication number | Publication date |
---|---|
JPWO2019194068A1 (en) | 2021-04-08 |
CN111902125A (en) | 2020-11-06 |
CN111902125B (en) | 2023-10-20 |
JP7255587B2 (en) | 2023-04-11 |
WO2019194068A1 (en) | 2019-10-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6565994B2 (en) | Oral composition | |
JP5251350B2 (en) | Dentifrice composition | |
JP5381685B2 (en) | Dentifrice composition | |
JP5310556B2 (en) | Oral composition and method for improving astringency of oral composition | |
JP2020011951A (en) | Oral composition | |
JP6766823B2 (en) | Oral composition | |
WO2018066341A1 (en) | Oral composition and method for suppressing discoloration of formulation and liquid separation thereof | |
JP2015117215A (en) | Dentifrice composition | |
KR20200141442A (en) | Oral composition and bitter taste improver of α-olefin sulfonate | |
JP5573120B2 (en) | Toothpaste composition | |
JP6409618B2 (en) | Dentifrice composition | |
JP2018203714A (en) | Oral composition | |
KR20180133220A (en) | Oral composition | |
KR20210008828A (en) | Oral composition | |
KR102531788B1 (en) | Oral composition and method for inhibiting discoloration thereof | |
JP6617535B2 (en) | Dentifrice composition | |
JP2001131041A (en) | Composition for oral use | |
JP7388126B2 (en) | Oral composition | |
JP7371351B2 (en) | Oral composition | |
JP6007780B2 (en) | Oral composition and oral biofilm remover | |
WO2016136719A1 (en) | Toothpaste composition | |
JP2024070036A (en) | Oral Composition | |
JP2010143846A (en) | Dentifrice composition | |
JP2006001901A (en) | Dentifrice composition | |
JP2007169198A (en) | Dentifrice composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |